Patient-Focused Drug Development: Methods to Identify What Is Important to Patients: Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 25, 2022
January 31, 2025
06de176c-365a-43ad-84f7-7aa3926833b5
Related Documents
General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
Guidance DocumentJuly 27, 2022Center for Drug Evaluation and Research
Patient-Focused Drug Development: Collecting Comprehensive and Representative Input
Guidance DocumentJune 13, 2018Center for Drug Evaluation and Research
Drug Product Tracing: The Effect of Section 585 of the FD&C Act
Guidance DocumentFebruary 3, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.